0000899243-18-003897.txt : 20180214 0000899243-18-003897.hdr.sgml : 20180214 20180214175031 ACCESSION NUMBER: 0000899243-18-003897 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180213 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kuno Sachiko CENTRAL INDEX KEY: 0001383384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33609 FILM NUMBER: 18614362 MAIL ADDRESS: STREET 1: 7501 WISCONSIN AVENUE STREET 2: SUITE 600E CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001365216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133929237 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 KING FARM BOULEVARD, SUITE 550 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 3019613400 MAIL ADDRESS: STREET 1: 805 KING FARM BOULEVARD, SUITE 550 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-13 1 0001365216 Sucampo Pharmaceuticals, Inc. SCMP 0001383384 Kuno Sachiko 28307 MALLARD DRIVE EASTON MD 21601 0 0 1 0 Class A Common Stock 2018-01-25 5 G 0 E 2000000 0.00 D 5137344 I By SK Impact Fund, LLC Class A Common Stock 2018-02-13 4 U 0 5137344 18.00 D 0 I By SK Impact Fund, LLC Disposed of upon expiration of the tender offer conducted by Sun Acquisition Co., a Delaware corporation ("Purchaser"), pursuant to the terms of the Agreement and Plan of Merger, dated as of December 26, 2017, among Sucampo Pharmaceuticals, Inc., a Delaware corporation (the "Issuer"), Mallinckrodt plc, an Irish public limited company ("Parent"), and Purchaser, a wholly owned subsidiary of Parent, whereby Purchaser offered to purchase each outstanding share of Class A Common Stock, par value $0.01 per share, of the Issuer at a purchase price of $18.00 per share in cash, subject to any required withholding of taxes and without interest. /s/ Kei Tolliver, by Power of Attorney 2018-02-14